Home › Drug Resistant Epilepsy › NCT07350551
Pediatric Epilepsy
Who can join
Ages 3 to 25 · All sexes
Full eligibility criteria
Inclusion Criteria: * Candidates will be those who are admitted to the Epilepsy Monitoring Unit and are able to participate in a pre-operative evaluation using depth intracranial electrodes. The candidacy is determined independently by the patient's treating physician as part of the patient's routine medical care. * Patients have drug-intractable epilepsy undergoing invasive monitoring in the EMU. Exclusion Criteria: * Determination by clinicians and investigators that a patient is unable to complete the behavioral tasks required for the protocol due to either cognitive limits, psychological limits, or pain.
About the study
The purpose of the research is to better understand how the human brain accomplishes the basic cognitive tasks of learning new information, recalling stored information, making decisions or choices about presented information and self-control. These investigations are critical to better understand human cognition and to design treatments for disorders of learning, memory, decision making and cognitive control.
What is being tested
- Cedrus RB series response pad; Adtech Behnke-Fried micro-electrodes; Neuralynx or Blackrock electrophysiology system; Blackrock Cerestim or Natus Nicolet stimulator (behavioral)
Sponsor: University of Texas Southwestern Medical Center · Participants: 200 · Started: Jul 1, 2026
Contact the study team
- Tashinga Mupambo · Phone: 214-645-1355
- Zhongzheng Fu · Phone: 214-648-3884
Official record on ClinicalTrials.gov — NCT07350551
Locations in the U.S.
| Texas | Children's Medical Center Dallas, Dallas |
Conditions
- Drug Resistant Epilepsy
- Epilepsy
- Brain Diseases
- Neurologic Diseases
- Attention Deficit Hyperactivity Disorder
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.